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Chronic alcohol consumption induces hepatic oxidative stress resulting in production of highly reactive
electrophilic α/β-unsaturated aldehydes that have the potential to modify proteins. A primary me-
chanism of reactive aldehyde detoxiﬁcation by hepatocytes is through GSTA4-driven enzymatic con-
jugation with GSH. Given reports that oxidative stress initiates GSTA4 translocation to the mitochondria,
we hypothesized that increased hepatocellular damage in ethanol (EtOH)-fed GSTA4/ mice is due to
enhanced mitochondrial protein modiﬁcation by reactive aldehydes. Chronic ingestion of EtOH increased
hepatic protein carbonylation in GSTA4/ mice as evidenced by increased 4-HNE and MDA im-
munostaining in the hepatic periportal region. Using mass spectrometric analysis of biotin hydrazide
conjugated carbonylated proteins, a total of 829 proteins were identiﬁed in microsomal, cytosolic and
mitochondrial fractions. Of these, 417 were novel to EtOH models. Focusing on mitochondrial fractions,
1.61-fold more carbonylated proteins were identiﬁed in EtOH-fed GSTA4/ mice compared to their
respective WT mice ingesting EtOH. Bioinformatic KEGG pathway analysis of carbonylated proteins from
the mitochondrial fractions revealed an increased propensity for modiﬁcation of proteins regulating
oxidative phosphorylation, glucose, fatty acid, glutathione and amino acid metabolic processes in
GSTA4/ mice. Additional analysis revealed sites of reactive aldehyde protein modiﬁcation on 26 novel
peptides/proteins isolated from either SV/GSTA4/ PF or EtOH fed mice. Among the peptides/proteins
identiﬁed, ACSL, ACOX2, MTP, and THIKB contribute to regulation of fatty acid metabolism and ARG1,
ARLY, and OAT, which regulate nitrogen and ammonia metabolism having direct relevance to ethanol-
induced liver injury. These data deﬁne a role for GSTA4-4 in buffering hepatic oxidative stress associated
with chronic alcohol consumption and that this GST isoform plays an important role in protecting against
carbonylation of mitochondrial proteins.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Alcoholic liver disease (ALD) is a major contributor of liver
failure in the United States today. A common phenotype of ALD is a
hepatocellular environment characterized by pronounced lipid
accumulation with enhanced oxidative stress [1,2]. In this pro-
oxidant environment, increased lipid peroxidation occurs resulting
in the accumulation of reactive aldehydes including 4-hydro-
xynonenal (4-HNE), 4-oxononenal (4-ONE), acrolein, and mal-
ondialdehyde (MDA) [3,4]. Following their production, the afore-
mentioned reactive aldehydes react with DNA as well as Cys, Lys,
and His residues within proteins [4].
In chronic ETOH models, we have identiﬁed numerous proteins
including the lipid phosphatase PTEN, protein kinase AMPKα and
molecular chaperone Grp78 as targets of electrophilic carbonyla-
tion by reactive aldehydes in vivo [5–7]. Concurrently, using mass
spectrometry and a global proteomic approach, we have char-
acterized the “lipid peroxidome” formed during chronic ETOH
administration [8]. From those seminal reports, it was determined
that increased lipid peroxidation due to ethanol consumption re-
sults in increased carbonylation of key proteins involved in cellular
metabolic pathways involved in fatty acid metabolism, drug me-
tabolism, oxidative phosphorylation, and the TCA cycle. Interest-
ingly, all of these hepatic pathways are reportedly impaired during
ALD [9–14].
An important mechanism for removal of toxic lipid aldehydes is
via conjugation with glutathione [15,16] by Glutathione S-trans-
ferase A4-4 (GSTA4) [17]. GSTA4 is a phase 2 detoxifying enzyme
whose expression is increased in response to oxidative stress. For
instance, the exposure of GSTA4 transfected HepG2 cells to lipid
aldehydes, including 4-HNE results in cellular resistance to toxicity
[18]. In chow-fed SV 129 mice, deletion of GSTA4 results in an age-
dependent increased propensity for obesity and increased lipid
peroxidation, a phenotype not evident in GSTA4 / C57BL/6J mice
[17]. Furthermore, consumption of a high fat diet increased adi-
pocyte oxidative stress and mitochondrial damage. Additionally,
deletion of GSTA4-4 signiﬁcantly enhances protein carbonylation
and hepatocellular damage following carbon tetrachloride (CCl4)
administration, further highlighting the importance of GSTA4 in
removal of lipid aldehydes [19].
In this study, we used the GSTA4/ mouse model treated
chronically with ethanol to identify and validate hepatic proteins
that are modiﬁed by electrophilic products of lipid peroxidation as
well as evaluate their involvement in the early stages of ALD. The
enhanced mass spectrometric techniques used in this study have
identiﬁed novel protein targets of reactive aldehydes associated
with chronic EtOH. Most importantly, the use of GSTA4 / mice
provide insight into hepatocellular mitochondrial systems im-
pacted by deranged detoxiﬁcation of electrophilic aldehydes gen-
erated by oxidative stress.2. Experimental methods
2.1. EtOH Administration
SV 129 WT (n¼7/group) and GSTA4 / (n¼6/group) male
mice were fed Lieber-DeCarli EtOH liquid diets containing EtOH, or
Lieber-DeCarli control liquid diet for 6 weeks. In the EtOH groups,
EtOH calories replaced carbohydrate calories. This group of ani-
mals was acclimated to the diet by increasing the percentage of
EtOH slowly to a maximum of 28% EtOH-derived calories as de-
scribed elsewhere [20]. At sacriﬁce, livers were weighed and
subcellular fractions (cytosolic, mitochondrial, microsomal) pre-
pared as previously described [2,6]. Pieces of freshly isolated he-
patic tissue were formalin-ﬁxed for further analysis. Blood alcoholconcentrations were determined using blood isolated during the
dark phase of housing as previously described [21].
2.2. Histological evaluation
Formalin ﬁxed slides were immunohistochemically evaluated
for 4-HNE, adipophilin (ADPH) (Fitzgerald, Ind. Acton, MA), or
MDA as previously described [6].
2.3. Biotin hydrazide puriﬁcation
Total carbonylated proteins were puriﬁed from 500 μg cytosolic
extracts (5PF/5EtOH SV/GSTA4-4/), mitochondrial extracts (5PF/
5EtOH SV/GSTA4-4 /) and microsomal extracts (4PF/4EtOH SV,
3PF/3EtOH GSTA4-4 /) following biotin hydrazide derivatization
(5 mM/2 h/RT/dark) and NaBH4 reduction (10 mM/100 mM NaOH
1hr/dark). Biotin hydrazide linked carbonylated proteins were in-
cubated along with an untreated pooled samples (negative con-
trol/background) overnight using Streptavidin HiTrap columns (GE
Biosciences) [8]. Columns were washed 5X in PBS/2 M Urea and
eluted with 0.1 M NH4OH. Elutions were dried down using a roto-
evaporator, resuspended in 6X SDS PAGE loading buffer and loaded
on 10% SDS PAGE gels. Gels were run for 20 min at or until the dye
front migrated approximately 1 cm into the resolving gel. Gels
were stained with Coomassie blue overnight and stained 1 cm
bands excised, destained, and digested with trypsin as previously
described [8]. Peptides were extracted, dried down, and re-
suspended in 0.1% formic acid in ddH2O before loading on the
mass spectrometer.
2.4. LC-MS/MS analysis
For LC-MS/MS analysis, 8μl of each peptide mixture in 0.1 M
formic acid was loaded on a Bruker Amazon Speed LC-MS/MS
(Bruker Daltronics, Billerica, MA). The instrument was operated
using data-dependent alternating collision-induced dissociation
(CID) MS/MS and electron transfer dissociation (ETD) with a
threshold of 10,000 total ion current (TIC). Data analysis was
performed using ProteinScape V3.1.2 (Bruker Daltonics Inc. Bill-
erica, MA) and Mascot (v2.1.04, Matrixscience). First a global
search for proteins was conducted with a Mascot cutoff score of 15
with the following variable modiﬁcations of carbamidomethly
(C) and oxidized (M) (Protein identiﬁcation conﬁdence value of
99%, peptide identiﬁcation conﬁdence value of 95%, Peptide tol-
erance: 0.5 Da, MS/MS tolerance: 0.5 Da with 2 missed cleavages).
After the initial search a second search was conducted for post-
translational modiﬁcation by reactive aldehydes using the masses
shown in Table S1. For this 2nd iteration, peptide signiﬁcance re-
quired a Mascot score higher than 22 and each spectra was ver-
iﬁed manually for false positive identiﬁcation.
2.5. Bioinformatics
UniProt IDs from proteins identiﬁed were initially converted
into gene symbols using the UniProt website (UniProt Release
2015_08) [22]. Gene symbols functionally annotated for KEGG
2015 pathways [23] using EnrichR [24]. Initially, pathways were
examined for over-representation in 6 different lists of proteins/
gene symbols derived from the mitochondrial fraction: (1) in 3
(50% of samples) or more samples from the PF/GSTA4-4/ group
and not in background; (2) in 3 (50% of samples) or more samples
from the EtOH/GSTA4-4/ group and not in background; (3) in 3
(50% of samples) or more samples from the PF/SV group and not in
background; 4) in 3 (50% of samples) or more samples from the
EtOH/SV group and not in background; (5) in 3 (50% of samples) or
more samples from all four groups (PF/EtOH SV/GSTA4-4/) and
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amine the pathways that were over-represented by proteins/gene
symbols that were identiﬁed in the GSTA4-4 / mice and not the
SV mice in the mitochondrial fraction, 3 additional lists were
constructed: (1) in 3 or more samples from the EtOH/GSTA4-4 /
group but less than 3 samples in the other 3 groups and not in
background; (2) in 3 or more samples from the PF/GSTA4-4 /
group but less than 3 samples in the other 3 groups and not in
background; and 3) in 3 or more samples from the
EtOH/GSTA4-4 / group and 3 or more samples from the
PF/GSTA4-4 / group but less than 3 samples in the 2 SV groups
and not in background. Pathways that were nominally signiﬁcant
(unadjusted p-Valueo0.01 in the initial comparison of 6 lists; p-
Valueo0.05 in the comparison of the 3 GSTA4-4 / exclusive
lists) in at least one of the lists were retained. When no proteins
from a list were found in the pathway, a p-Value of 1 was assumed.
Hierarchical clustering was used to describe the relationships
among the enriched pathways with respect to their signiﬁcance in
the compared lists, i.e., pathways that are enriched in the same
groups clustered together. Hierarchical clustering was done using
Euclidean distance between binary indicators of signiﬁcance
(po0.05 vs. p4¼0.05). The hierarchical clustering analysis and
the heatmap were generated using R Statistical Software (version
3.2.1).
2.6. Statistical analysis
The data are presented as means7SE. Comparisons between
genotype and diet were accomplished by two-way ANOVA, fol-
lowed by Student Newman-Keuls post hoc analysis. Comparisons
between two groups was accomplished by Student's T-test. Sta-
tistical signiﬁcance was set at Po0.05. Prism 5 for Windows
(GraphPad Software, San Diego, CA) was used to perform all sta-
tistical tests.Fig. 1. Effects of chronic EtOH on hepatic lipid accumulation and ﬁbrosis in SV and
immunohistochemically using polyclonal antibodies directed against ADPH (Panels A–D
tissue sections (Original magniﬁcation 400X). Middle panels (E–H); Picrosirius red stain
light exposure of picrosirius red staining. Figures are representative of three PF/EtOH g3. Results
As we previously reported, this 6 week model of chronic ethanol
consumption, by GSTA4/ mice resulted in a signiﬁcant increase in
hepatocellular steatosis and liver triglycerides [23]. Whereas the mean
ALT value was 2-fold higher in ethanol-fed GSTA4-4/ mice
(74.8715.1), as compared to the respective pair-fed controls
(35.5714.8), a large variation in responses of individual animals re-
sulted in a trend towards higher levels of necrosis (po0.06) but did
not achieve statistical signiﬁcance [20]. In the present study, we have
extended these previously published results by exploring the effects
EtOH in combination with GSTA4 / on protein carbonylation. To
further expand our previous observations, lipid accumulation was
examined by immunohistochemical analysis of adipophilin (ADPH,
perilipin 2, PLIN2), a validated marker hepatocyte lipid accumulation
as well as unstimulated stellate cells which contain retinoic acid rich
vesicles [25]. Thus, ADPH is an ideal marker for determining both
steatosis as well as the transition of hepatic stellate cells to an active
state, which is signaled by retinoic acid release. As shown in Fig. 1
(Panels A–D), liver sections prepared from SV PF or ETOH-fed mice
show only ADPH positive staining in stellate cells with no evidence of
hepatocellular lipid accumulation. Interestingly, pair-fed (PF),
GSTA4 / mice exhibited obvious hepatocellular lipid accumulation
with no indication of retinoic acid loss from stellate cells. However, the
chronic ingestion of EtOH by GSTA4/ mice markedly increased
ADPH staining, reﬂecting increased lipid accumulation within hepa-
tocytes. To further explore the effects of 6-weeks consumption of EtOH
on hepatocellular pathology in GSTA4 / mice, ﬁbrosis was evaluated
by picrosirius red staining and αSMA immunohistochemistry. Based
on the images in Fig. 1(Panels E–M), there is no apparent difference in
Sirius red staining in either group. Nor was there a signiﬁcant increase
in αSMA staining evident after this relatively short period of EtOH
exposure (Data not shown). These data suggest that following short
term administration of EtOH, deletion of GSTA4 contributes primarily
to hepatocellular lipid accumulation without detectable stellate cellGSTA4/ mice. Parafﬁn embedded formalin ﬁxed tissue sections were analyzed
) or stained with Sirius red (Panels E–M). Top panels (A–D); adipophilin staining of
ing of liver sections (original magniﬁcation 200X). Bottom panels (I–M); Polarized
roups of SV and GSTA4/ mice respectively.
Table 1
Total number of proteins identiﬁed to be carbonylated in each fraction. 500 μg of
cytosolic (cyto), mitochondrial (mito) and microsomal (micro) extracts were trea-
ted with biotin hydrazide and subjected to LC-MS/MS analysis as described in
methods.
Table 1 Fraction Number of animals
used
# Identiﬁed proteins
All fractions (PF/EtOH) All 20 829
SV PF mito 5 214
SV EtOH mito 5 230
GSTA4/ PF mito 5 389 (þ1.81-fold)
GSTA4/ EtOH mito 5 371 (þ1.61-fold)
SV PF cyto 5 238
SV EtOH cyto 5 244
GSTA4/ PF cyto 5 224 (0.06-fold)
GSTA4/ EtOH cyto 5 195 (0.13-fold))
SV PF micro 4 209
SV EtOH micro 4 191
GSTA4/ PF micro 3 116 (0.45-fold)
GSTA4/ EtOH micro 3 133(0.31-fold)
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We previously reported that ingestion of EtOH results in an in-
crease in hepatic 4-hydroxynonenal staining and serum levels of auto-
antibodies directed against MDA-adducted proteins levels in
GSTA4/ mice [20]. To determine if increases hepatocellular protein
modiﬁcation by MDA occurs in tandemwith increased serum levels or
MDA antibodies, liver sections prepared from PF and EtOH-fed
SV/GSTA4 / were examined for post-translational modiﬁcation by
either MDA or 4-HNE (Fig. 2). In the GSTA4 / mice, sections pre-
pared from both PF and EtOHmice displayed signiﬁcantly more 4-HNE
staining compared to their SV counterparts. Consistent with our pre-
vious report of increased anti-MDA antibody concentrations following
chronic ethanol treatment, EtOH ingestion markedly increased MDA
staining in the GSTA4 / genotype with ethanol-consuming mice
displaying the most intense staining.
We recently employed biotin hydrazide derivatization followed
by global LC-MS/MS analysis to identify carbonylated proteins in
cellular fractions (cytosolic, mitochondrial and microsomal) iso-
lated from PF/EtOH fed C57BL/6J mice [8]. In that study, individual
samples collected from PF and EtOH-fed animals were pooled
within their respective treatment groups for analysis. In the pre-
sent study, however, we examined hepatocellular extracts for
protein carbonylation in fractions prepared from individual mice
to evaluate animal-to-animal replication of treatment-speciﬁc
hepatic protein modiﬁcations. In addition, for negative controls,
untreated whole cell extracts were pooled, puriﬁed by streptavidin
and processed. As shown in Table 1 and Table S2, a total of 829
carbonylated proteins, collectively, were identiﬁed in cytosolic,
mitochondrial and microsomal samples prepared from PF and
EtOH-fed SV and GSTA4 / mice. Of these, 326 proteins were
previously identiﬁed in C57BL6J mice subjected to the same EtOH
feeding regimen but 417 have not been previously identiﬁed in
murine EtOH models [8]. Surprisingly, 47 proteins were identiﬁed
in our untreated samples. Data presented in Table 1 demonstrate
that when compared to PF SV mice, the number of carbonylated
proteins identiﬁed in PF/EtOH fed GSTA4 / mice is markedly
higher (1.6–1.8 fold) in the mitochondrial fraction but the same
increase is not evident in the cytosolic or microsomal fractions.
3.1. Bioinformatic analysis of mitochondrial carbonylated pro-
teins in PF/EtOH fed SV/GSTA4 / mice.
To identify proteins preferentially targeted by carbonylation inFig. 2. Effects of chronic EtOH on hepatic protein carbonylation in SV and GSTA4
munohistochemically using polyclonal antibodies directed against 4-HNE and MDA.
respectively.GSTA4 / mice a threshold was established that required proteins
to be identiﬁed in at least 50% of animals (mitochondrial, cytosolic
and microsomal proteins). As shown in Table S3, 342 proteins
were identiﬁed in at least 50% of the animals in any group. From
the Venn diagram presented in Fig. S1, 119 proteins were common
to all 4 groups. Examining the effect of EtOH, approximately 2-fold
more proteins were unique in the SV EtOH group when compared
to SV PF controls. In comparison, the GSTA4 / PF displayed a
3-fold increase of unique proteins when compared to respective
SV controls indicating that protein carbonylation is increased in
GSTA4 / mice fed diets high I polyunsaturated fats, even in the
absence of EtOH consumption. Examining the effects of EtOH and
GSTA4 / , EtOH induced carbonylation of 22 unique proteins.
In murine models, chronic EtOH reportedly impairs mi-
tochondrial function contributing to hepatocyte death [13]. During
conditions of increased oxidative stress, GSTA4 reportedly localizes
to mitochondria [26,27]. In adipose tissue, deletion of GSTA4 in-
duces mitochondrial dysfunction [28]. As evidenced by the car-
bonylated proteins identiﬁed, in the liver GSTA4 deletion increases
mitochondrial protein carbonylation up to 1.8-fold when com-
pared to respective SV PF/EtOH groups (Table 1). Due to the in-
crease in the number of mitochondrial carbonylated proteins in
GSTA4 / mice, subsequent analyses’ were focused on 235/ mice. Parafﬁn embedded formalin ﬁxed tissue sections were analyzed im-
Figures are representative of three PF/EtOH groups of SV and GSTA4/ mice
Fig. 3. Venn diagram showing the distribution of mitochondrial proteins in
SV/GSTA4 / PF and EtOH fed mice. Diagram was prepared as described in
Methods using mitochondrial proteins identiﬁed as carbonylated in at least 50% of
mice in each group.
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mice in each group. From the Venn diagram presented in Fig. 3 andFig. 4. KEGG Pathway Bioinformatic analysis of mitochondrial proteins. For enrichment a
group are represented in each column. The SV-PF column represents pathways enrich
background sample. The GSTKO-PF column represents pathways enriched for proteins i
sample. The SV-EtOH column represents pathways enriched for proteins identiﬁed in at le
EtOH column represents pathways enriched for proteins identiﬁed in at least 50% of the
‘all 4 groups’ represents pathways enriched for proteins identiﬁed in at least 50% of sam
sample. The background column represents pathways enriched for proteins identiﬁed in
were examined for enrichment using EnrichR [24]. KEGG pathways that were nominally
The colors of the heatmap range fromwhite (unadjusted p-Value40.05) to bright red ba
used when the KEGG pathway was not represented by any proteins in the list. KEGG
distance and a binary indicator of signiﬁcance (po0.05 vs. p4¼0.05).Table S4, 63 proteins were common to all 4 groups. Examining the
distribution of proteins unique to each genotype, there were sig-
niﬁcantly more mitochondrial proteins identiﬁed in either
GSTA4 / PF (43 GSTA4 / PF/2SVPF), GSTA4 / EtOH fed (23
GSTA4 / EtOH/1SV EtOH) and both GSTA4/PF/EtOH (49
GSTA4 / PF/EtOH vs 1SVPF/EtOH) mice as compared to the re-
spective SV groups. This difference strongly supports the con-
tribution of GSTA4 in removal of mitochondrial reactive aldehydes.
Furthermore, both GSTA4/ PF and GSTA4 / EtOH exhibited
clear differences in patterns of protein carbonylation suggesting
inﬂuences from both the PF diet and by EtOH.
To further determine pathway speciﬁc effects of increased mi-
tochondrial protein carbonylation, KEGG analysis was performed
on proteins identiﬁed in the mitochondrial fractions. As a negative
control, analysis included proteins identiﬁed as background from
our untreated samples. From the pathway analysis using the KEGG
database, in all groups, carbonylation of proteins implicated in
fatty acid, xenobiotic, butanoate and amino acid metabolism
(Fig. 4, Table S5). As shown, deletion of GSTA4 contributed to in-
creased carbonylation of proteins regulating urea, bile acid, gly-
colytic, oxidative phosphorylation, amino acid and glutathione
metabolism.
To further focus our bioinformatic analyses’, an additional
KEGG analysis was performed using only mitochondrial proteins
that were identiﬁed as unique to GSTA4 / PF/EtOH (49 proteins)
or PF (43 proteins) or EtOH groups (23 proteins). From Fig. 5 and
Table S6, of the proteins unique to GSTA4 groups, EtOH con-
sumption induced a propensity for carbonylation of glyoxylate
cycle and carboxylate cycle proteins whereas PF inducednalysis, six groups of proteins were identiﬁed and enrichment of pathways for each
ed for proteins identiﬁed in at least 50% of the pair-fed 129 mice, but not in the
dentiﬁed in at least 50% of the pair-fed GSTA4/ mice, but not in the background
ast 50% of the ethanol-fed 129 mice, but not in the background sample. The GSTKO-
ethanol-fed GSTA4/ mice, but not in the background sample. The column labeled
ples in each of the four groups (PF/EtOH SV/GSTA4 /), but not in the background
the background sample. Proteins functionally annotated using KEGG pathways [23]
signiﬁcant (po0.01) in at least one of the 6 protein lists are included in the graphic.
sed on the log base 10 transformation of the unadjusted p-value. A p-Value of 1 was
pathways (rows) are ordered based on hierarchical clustering using the Euclidean
Fig. 5. KEGG Bioinformatic analysis of mitochondrial carbonylated proteins unique to GSTA4/ PF, GSTA4/ EtOH or PF/EtOH groups. For enrichment analysis, three
groups of proteins were identiﬁed and enrichment of pathways for each group are represented in each column. The GSTKO-PF only column represents pathways enriched for
proteins identiﬁed in at least 50% of the pair-fed GSTA4/ mice, but less than 50% of samples in all three of the other groups and not identiﬁed in the background sample.
The GSTKO-EtOH only column represents pathways enriched for proteins identiﬁed in at least 50% of the ethanol-fed GSTA4/ mice, but less than 50% of samples in all
three of the other groups and not identiﬁed in the background sample. The GSTKO-EtOH and PF only column represents pathways enriched for proteins identiﬁed in at least
50% of the ethanol-fed GSTA4/ mice and at least 50% of pair-fed GSTA4 / mice, but less than 50% of samples in the SV groups and not identiﬁed in the background
sample. Proteins functionally annotated using KEGG pathways [23] were examined for enrichment using EnrichR [24]. KEGG pathways that were nominally signiﬁcant
(po0.05) in at least one of the 3 protein lists are included in the graphic. The colors of the heatmap range fromwhite (unadjusted p-Value40.05) to bright red based on the
log base 10 transformation of the unadjusted p-value. A p-value of 1 was used when the KEGG pathway was not represented by any proteins in the list. KEGG pathways
(rows) are ordered based on hierarchical clustering using the Euclidean distance and a binary indicator of signiﬁcance (po0.05 vs. p4¼0.05).
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bolic pathways. Examining proteins unique to both groups, in-
creased carbonylation was evident in fatty acid, amino acid and
xenobiotic metabolic pathways.
To determine if there are common proteins modiﬁed in each
animal representing each treatment group, carbonylated proteins
were examined that were present in all of the 5 animals in all of
the respective treatment groups (Table S7, S8). A signiﬁcant
number of proteins (19) were identiﬁed in all samples evaluated.
These include aldehyde dehydrogenase isoform 2 (ALDH2), heat
shock protein 71 kDa (HSP7C, HSPA8), mitochondrial glutathione
S-transferase (MGST1), and protein disulﬁde isomerase isoform A6
(PDIA6) all of which have been identiﬁed as targets of protein
carbonylation [8]. In the SV PF and EtOH alone or PF/EtOH com-
bined groups only 7 proteins were carbonylated in all animals. Of
the proteins identiﬁed in GSTA4 / mice, 19 proteins were iden-
tiﬁed in all 5 GSTA4 / PF mice, 13 protein targets in all 5
GSTA4 / EtOH mice and a total 21 proteins found in all mice in
both GSTA4 / PF/EtOH groups. These data reinforce the con-
tribution of GSTA4 in removal of reactive aldehydes generated
within the mitochondria. Of interest, a predominance of cyto-
chrome P450 isozymes and fatty acid metabolic enzymes were
identiﬁed as carbonylated in the GSTA4 / groups, indicating the
possibility for defects in hepatocellular detoxiﬁcation and lipid
accumulation. This phenomenon further increased with the ad-
dition of EtOH in GSTA4 / mice as evident by carbonylation ofcellular detoxiﬁcation enzymes (glutathione S-transferase isoform
P1 (GSTπ), cytochrome P450 1A2 (CYP1A2), cytochrome P450
2C50 (CYP2C50) and fatty acid metabolic proteins (3-ketoacyl-CoA
thiolase A (ACAA1A, THIKA), long chain speciﬁc Acyl-CoA dehy-
drogenase (ACADL). Carbonylation of these proteins could con-
tribute to increased lipid accumulation as well as altered GST ac-
tivity during chronic EtOH consumption [1,2,8].
Using tissue extracts from animal models, identiﬁcation of
in vivo sites of carbonylation has proven to be a difﬁcult task.
Confounding factors that contribute to the paucity of identiﬁcation
of sites of carbonylation from proteins collected from animal tissue
include the relative abundance of total peptides compared to
carbonylated peptides recovered and identiﬁed, aldehyde adduct
stability as well as instrument sensitivity. In our previous work
using collision induced dissociation LC-MS/MS, pooled samples
and post-translational modiﬁcation by 4-HNE, 4-ONE, acrolein and
MDA, we identiﬁed 8 novel peptides that were carbonylated in PF/
EtOH fed C57BL/6J mice [8]. In the present study, protein isolated
from individual (PF/EtOH-fed, SV/GSTA4 / , (cytosolic, micro-
somal and mitochondrial fractions) animals were combined with a
Bruker Amazon Speed CID/ETD mass spectrometer to examine
post-translational modiﬁcation of Cysteine, Lysine or Histidine
residues by acrolein, MDA, 4-HNE, 4-ONE, 4-HHE, crotonaldehyde,
2-pentenal, 2-hexenal, 2-heptenal, 2-octenal and 2-nonenal [29].
To enhance peptide statistical stringency, Protein Prospector false
positive peptides were discarded regardless of MASCOT score and
Fig. 6. Representative tandem mass spectra of in vivo adducted peptides isolated from proteins regulating fatty acid and nitrogen metabolism. (A) ACSL (B) ACLY.
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Table S9, 26 novel peptides were determined to possess aldehyde
modiﬁcation of on Cys, Lys or His residues. Of these, carbonylated
proteins were identiﬁed in all fractions, both diets and all geno-
types. Examining amino acid preference, no obvious differences
were detected between speciﬁc amino acids modiﬁed and type of
aldehyde modiﬁcation. Importantly, deletion of GSTA4 resulted in
increased carbonylated peptide identiﬁcation when compared to
respective SV groups. Of particular relevance to ALD are peptides
derived from ACSL1, peroxisomal acyl-coenzyme A oxidase 2
(ACOX2), MTP, and THIKB, all of which assist in regulating hepa-
tocellular fatty acid homeostasis. In addition, arginase (ARG1),
argininosuccinate lyase (ARLY) and ornithine aminotransferase
(OAT) are central for regulation of hepatic ammonia detoxiﬁcation
while aldehyde dehydrogenase isoform 2 (ALDH2) plays an im-
portant role in the detoxiﬁcation of ethanol-derived acetaldehyde.
HSP7C (HSP8) is a house-keeping chaperone assisting in preven-
tion of protein aggregation [30] while fructose-bisphosphate al-
dolase B (ALDOB), ATP synthase subunit alpha (ATPA), Pyruvate
carboxylase (PYC), Succinate dehydrogenase (SDHA) regulate glu-
cose and ATP metabolism. The tandem mass spectra for these
peptides are shown in Fig. 6 and Supplemental Fig. 1.4. Discussion
Chronic ethanol consumption causes liver damage through
dysregulation of a number of complex hepatocellular pathways. A
major contributor to alcohol-induced liver injury is enhanced
oxidative stress and the resulting increase in lipid peroxidation.
Previous studies from our laboratory using murine models have
demonstrated that chronic ethanol consumption results in in-
creased hepatic protein carbonylation by reactive aldehydes in-
cluding 4-HNE, 4-ONE, MDA, and acrolein [5,6,8]. In those studies,
protein carbonylation resulted in signiﬁcant enzyme inhibition
potentially contributing to ALD. In our early work, proteinidentiﬁcation was performed using 2-dimensional electrophoresis
followed by spot excision and subsequent identiﬁcation by mass
spectrometry. Due to technical difﬁculties, including antibody
sensitivity and protein abundance, early attempts identiﬁed only a
few proteins. Most recently, we have employed a global biotin
hydrazide derivatization/streptavidin puriﬁcation of cellular frac-
tions to identify signiﬁcantly more proteins that are carbonylated
in ALD [8,31]. In the present report, we further extend our studies
on protein carbonylation using GSTA4/ mice, which are more
susceptible to protein carbonylation, as well as the technical ad-
vances using fast-switching CID/ETD fragmentation. In addition,
the LC-MS/MS search database has been expanded to include
masses for Michael addition products of 4-HHE, 2-pentenal,
2-hexenal, 2-heptenal, 2-octenal and 2-nonenal resulting in sig-
niﬁcantly more peptides identiﬁed. Furthermore, carbonylated
proteins were isolated from livers of individual mice and pro-
cessed separately, whereas our previous study utilized pooled
fractions [8]. Using these experimental approaches, a total 829
carbonylated proteins are identiﬁed in the mouse models used in
this study. Of these, 417 have not been previously reported in
chronic EtOH models.
Mitochondria are proposed to be a primary target organelle
impacted by chronic ethanol ingestion. This proposition is con-
sistent with reports of suppressed ATP production, increased
acetate and increased protein acetylation animal models of ALD
[13,32,33]. In a related study, EtOH also decreased glycolytic
function. Research has demonstrated that following 4-weeks
consumption of EtOH, increased oxidation of mitochondrial DNA is
evident. Using both global approaches and immunoprecipitation
techniques, mitochondrial proteins are primary targets of lipid
peroxidation supporting the hypothesis that increased mitochon-
drial oxidative stress and lipid peroxidation/protein carbonylation
contribute to mitochondrial dysfunction [8,34]. Andringa et al.
determined that 4-HNE modiﬁcation of electron-transfer-ﬂavo-
protein, alpha polypeptide (ETFα) and dimethylglycine dehy-
drogenase (DMDH), enoyl CoA hydratase, and cytochrome c
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4-HNE was considered whereas in the present study our searches
incorporated proteins modiﬁed by a spectrum of reactive alde-
hydes that have been previously reported to contribute to cellular
damage [29,35–37]. In the present study, deletion of GSTA4 en-
hanced mitochondrial carbonylation by 1.8-fold when compared
to SV groups reﬂecting the contribution of this GSH-conjugating
enzyme in general detoxiﬁcation of mitochondrial lipid aldehydes
[19]. Of interest, from bioinformatic approaches, increased carbo-
nylation of the oxidative phosphorylation pathway was evident
(Figs. 4,5 and Table S5). Protein modiﬁcation of electron transport
chains would result in decreased ATP production contributing not
only to mitochondrial dysfunction but hepatocellular dysfunction
following EtOH consumption. Concurrently increased carbonyla-
tion of fatty acid, urea and detoxiﬁcation pathways is increased
which may contribute to increased lipid accumulation and oxi-
dative damage evident in both PF and EtOH-fed GSTA4/ mice.
A hallmark of chronic alcohol consumption is the reduction of
hepatocellular GSH resulting in decreased redox capacity and in-
creased protein carbonylation [8]. Dysregulation of hepatocellular
detoxiﬁcation and oxidative stress pathways clearly contributes to
cellular damage [2]. Previously, increased carbonylation of HSP72,
HSP90, glucose regulated protein 78 (GRP78) and protein disulﬁde
isomerase (PDI) have been demonstrated in ALD [7,38–41]. In the
present study, we ﬁnd that carbonylation of GSTπ, PDIA3, UDP-
glucuronyl transferases UGT1A1 and UGT2B1 is a consequence of
GSTA4 deletion. Of these 4 proteins, polymorphisms of GSTπ are
associated with increased human susceptibility to alcoholic cir-
rhosis and the involvement of PDIA3 in protein folding is dysre-
gulated in ALD [42,43]. Therefore, carbonylation of these proteins
could impair their function exacerbating the hepatocellular da-
mage resulting from chronic ethanol ingestion.
Hepatic lipid homeostasis is regulated transcriptionally and
post-translationally by changing levels of β-oxidation, lipid
synthesis, and lipid transport. Defects in all three of these path-
ways have been described to contribute to increases in lipid ac-
cumulation in ALD [9,44,45]. Protein carbonylation can alter ac-
tivity of enzymes in β-oxidation and increased carbonylation of
AMPKα contributes to dysregulation of activation in β-oxidation
following EtOH consumption in C57BL/6J mice [5]. In the present
study, we have identiﬁed nearly all of the proteins regulating β-
oxidation as targets of reactive aldehydes. Furthermore, site spe-
ciﬁc adducts are identiﬁed in Acyl-CoA Synthetase Long-Chain
Family Member 1 (ACSL1C242MDA), 3-ketoacyl-CoA thiolase B
(ACAA1, THIKBK293MDA), microsomal triglyceride transfer protein
(MTPK414MDA) and Acyl-CoA Oxidase 2 (ACOX2K556ONE). Aldehyde
modiﬁcation of any of these proteins could inhibit enzymatic ac-
tivity and promote lipid accumulation. These results provide a
potential mechanistic basis for the reports that chronic alcohol
abuse signiﬁcantly impairs hepatic β-oxidative processes [10,14].
Future studies are necessary to determine the molecular outcome
of carbonylation on overall ACSL1, THIKB, MTP, and ACOX2 activity.
Collectively, the data presented here demonstrate reactive alde-
hyde modiﬁcation of numerous enzymes regulating fatty acid
oxidation suggesting this as an important mechanism underlying
hepatic lipid accumulation in ALD.
Surprisingly, in our previous report, we identiﬁed apolipopro-
tein E (ApoE), non-speciﬁc lipid transfer protein (NLTP), MTP and
Ras-related protein Rab-1 as putative lipid droplet associating
proteins that are carbonylated. In this study, all of the aforemen-
tioned proteins were identiﬁed as well as ApoA, ApoB and nu-
merous additional Rab GTPases. Furthermore, hepatocellular da-
mage and steatosis is increased in GSTA4/ mice compared to
our previous C57BL/6J model. Increased steatosis would provide
additional lipid substrates for peroxidation and contribute to the
observed increased in protein modiﬁcation. Future studies will benecessary to determine the ramiﬁcation of carbonylation of lipid
droplet associated proteins on defects in lipid transport during
chronic EtOH consumption.
The identiﬁcation of protein adducts in PF control mice is in-
triguing. Increased lipid peroxidation and protein carbonylation
are also contributing factors in the pathogenesis of nonalcoholic
steatohepatitis (NASH). In a recent publication, increased serum
lipid peroxidation strongly correlated with NASH severity in hu-
man patients [46–48]. Furthermore, in a murine model of NASH
(MCD-methionine-choline deﬁcient), increased oxidative stress
contributed to stimulation of both the adaptive and humoral im-
mune response [49]. Examining the effects of the PF diet,
GSTA4 / mice presented with increased carbonylation compared
to the PF-SV group supporting the hypothesis that deletion of
GSTA4-4 contributes to enhancement of oxidative stress-induced
protein carbonylation.
In binge and chronic EtOH models, hepatic ammonia con-
centrations are signiﬁcantly elevated indicative of dysregulation of
ammonia detoxiﬁcation [41,50,51]. Using a long-term EtOH ad-
ministration model, urea synthesis was signiﬁcantly decreased but
activity of ornithine transcarbamoylase (OTC) and carbamyl
phosphate synthetase (CPS) were not signiﬁcantly different be-
tween PF and EtOH fed groups [52]. We previously reported that
ammonia metabolism/urea biosynthesis pathways are signiﬁcant
targets of reactive aldehydes during chronic EtOH consumption
[8]. In that study, all 5 proteins of the urea cycle (ARG1, ASSY, ARLY,
CPS1, OTC) were identiﬁed as targets of carbonylation. In the
present study, we have extended these ﬁndings by showing the
same proteins are carbonylated in ethanol-treated GSTA4 / but
now have identiﬁed site-speciﬁc aldehyde adducts on arginino-
succinate lyase, ornithine aminotransferase and arginase. Inhibi-
tion of ArlyK288HNE and Arg1K211acrolein could contribute to in-
creased ammonia concentrations found in ALD. However, inhibi-
tion of OatK374acrolein could be beneﬁcial. Clearly the functional
outcomes of carbonylation of these proteins in this complex
pathway of ammonia processing in the etiology of ALD remain to
be elucidated.
Fig. 7, presents an overall scheme of the results reported here
which directly depict the contribution of GSTA4 in mitochondrial
detoxiﬁcation of reactive aldehydes produced as a consequence of
oxidative stress and lipid peroxidation. Collectively, the data pre-
sented here reinforce the importance of lipid peroxidation and
protein carbonylation in ethanol-induced changes in hepatocel-
lular lipid accumulation, dysregulation of urea metabolism and
antioxidant responses. We stress however, that each protein
identiﬁed in this study will require individual analysis to de-
termine the speciﬁc effects of carbonylation. Concurrently, al-
though we present our negative control data (Table S2 far right
column), many of the targets that are identiﬁed in the untreated
samples have previously been identiﬁed as targets of carbonyla-
tion using alternative methods such as 2-dimensional electro-
phoresis and 4-HNE antibodies (actin, aldehyde dehydrogenases,
heat shock proteins) [41,53,54]. This indicates that there are pro-
teins that are carbonylated but will also bind nonspeciﬁcally to
streptavidin columns. Given these ramiﬁcations each protein that
is identiﬁed will need to be further examined using multiple
techniques to determine the effects of carbonylation. Therefore
these proteins have not been removed from our overall list. Fur-
ther, we stress that the effects of each carbonylated peptide will
also require additional study. These studies do validate the bene-
ﬁts of collection and analyses of liver from individual mice and
well as the use of CID/ETD to identify novel adducted peptides and
their speciﬁc sites of modiﬁcation providing new mechanistic in-
formation concerning the involvement of reactive aldehydes in
ALD.
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